BridgeMD
New treatment option for Post COVID-19 Condition
Official title Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation
ClinicalTrials.gov ID: NCT06865222
What this study is testing
- What it's testing
- The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients who have had a recent episode of COVID-19 and who present to the Post COVID-19 Clinic at Mayo Clinic Rochester with at least one of the PCC...
- At least one of the PCC symptoms of interest:
- Anosmia: Olfactory Threshold Test scores corresponding to Anosmia or Hyposmia
- Tinnitus: \>0 score on Tinnitus Handicap Inventory (not present prior to SARS-COVID 2 infection)
- Fatigue: Total Modified Fatigue Impact Scale (MFIS) Score of 40 or above
You likely can't join if
- Implanted electronic devices, including pacemakers, defibrillators, implant medication pumps, or vagus nerve stimulators (VNS)
- Active alcohol abuse: \>14 drinks a week or formal diagnosis, illicit drug use or drug abuse
- Any seizure history within the past 10 years
- Intracranial implant within 30 cm of magnet (e.g., aneurysm clips, endovascular coil, cerebral shunts, brain stimulators, cochlear implants, stents...
- Enrolled or plans to enroll in an treatment trial during this study
- Previous stroke with residual deficits
See the full eligibility criteria
- Patients who have had a recent episode of COVID-19 and who present to the Post COVID-19 Clinic at Mayo Clinic Rochester with at least one of the PCC symptoms of interest - anosmia, tinnitus, fatigue. Symptoms consistent...
- At least one of the PCC symptoms of interest:
- Anosmia: Olfactory Threshold Test scores corresponding to Anosmia or Hyposmia
- Tinnitus: \>0 score on Tinnitus Handicap Inventory (not present prior to SARS-COVID 2 infection)
- Fatigue: Total Modified Fatigue Impact Scale (MFIS) Score of 40 or above
- Implanted electronic devices, including pacemakers, defibrillators, implant medication pumps, or vagus nerve stimulators (VNS)
- Active alcohol abuse: \>14 drinks a week or formal diagnosis, illicit drug use or drug abuse
- Any seizure history within the past 10 years
- Intracranial implant within 30 cm of magnet (e.g., aneurysm clips, endovascular coil, cerebral shunts, brain stimulators, cochlear implants, stents, or electrodes) or any other metal object within or near the head...
- Enrolled or plans to enroll in an treatment trial during this study
- Previous stroke with residual deficits
- people unable to comprehend or follow verbal commands
- people unable to comprehend and sign the informed consent
- Based on PI's or local physician's assessment that subject unable to tolerate the trial procedure due to medical condition
- Clinical abnormality or clinically unstable medical condition, as indicated by medical history, physical examination, or clinical laboratory testing, that in the Investigator's judgment might pose a potential safety...
- Pregnant or trying to become pregnant; negative urine pregnancy test at screening will be required for females of childbearing potential
- Any condition which in the judgment of the investigator would prevent the subject from completion of the study
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.